Nasdaq:US$36.45 (-2.83) | HKEX:HK$60.55 (+0.00) | AIM:£5.37 (-0.28)
Search Result
Previous Article   |   Next Article
Announcements & Press Releases, Oncology / Immunology | 5 Nov 2009

Successful Global Phase IIb Ulcerative Colitis Trial for HMPL-004: All Primary and Secondary Endpoints Achieved Hutchison MediPharma Proceeding with Development and Partnership Plans

1 items
a091105